Tyranitar #222 Pokemon Evoluzioni a Paldea

Tyranitar #222 — Evoluzioni a Paldea
Current Market Price
€40
(as of 6 Jul 2026, in Good condition)
DemandNumber of cards being soldVery High
SupplyNumber of cards on the market right nowLow
LiquidityHow quickly you can expect to sell at the current market priceVery High

Prices by Condition

Basato sulle inserzioni attive in inglese su CardMarket. Per evitare valori anomali, i prezzi usano la 2ª inserzione più bassa per condizione (o la più bassa quando ce ne sono meno di 3).

ConditionPriceMinOffers
Near Mint€45€443
Excellent€40€394
Good€40€402
Light Played€400
Played€40€451
Poor€310

Cronologia vendite CardMarket

last 90d

172 vendite negli ultimi 90 giorni

DataCondizionePrezzo

Sblocca tutte le vendite — per condizione, lingua, venditore e prezzo, più le vendite gradate. Incluso in Collector.

Card Information

Pokemon
Tyranitar
Number
#222 / 193
Set
Evoluzioni a Paldea
Rarity
Rara illustrazione
HP
180
Type
Oscurità
Stage
Livello 2
Evolves from
Pupitar
Retreat
3
Illustrator
Nurikabe
Regulation
G
Weakness
Erba ×2
OStanamento
30+

Questo attacco infligge 30 danni in più per ogni Pokémon nella panchina del tuo avversario.

OOMonte della Paura
230

Scarta le prime quattro carte del tuo mazzo.

Market price overview for Tyranitar #222 from Evoluzioni a Paldea

Current pricing

At present, Tyranitar from Evoluzioni a Paldea trades at €40 in Good shape — there are 10 listings on the market right now. In Near Mint condition, the going rate is €45.

Price trend

Tyranitar saw a minor +3% price shift this month. The market is largely stable.

Demand & supply

With sales on 26 of 30 days, Tyranitar has a reasonable market, and supply is thin — just 10 copies are up for sale.

Price history (90 days)

Price history shows Tyranitar moving between €27 and €77 over the last 3 months. The price is mid-range right now.

Prices by condition

Depending on condition, you'll pay anywhere from €31 (PO) to €86 (MT) for Tyranitar.

Buy or sell?

Tyranitar is on an upward trajectory. Sellers listing now may benefit from the momentum.

Frequently Asked Questions